Ok so let me get this straight. Pfizer is willing to pay $100 Billion for Astranzeneca and we don't believe that some company is going to jump in and buy MNKD. You have to be kidding. Patents expiring and the only way to grow is not organic
In addition to adding to the world wide humor as snakes and such, there is IMO a more sinister side to these law firms. Basically, if an investor decides to join the class action in a majority of the cases he/she finds out at the end that their paper work was inaccurate and, thus, it has been denied. The telephone number that the investor is given to call connects him/her to a recording prohibiting the ability to understand WHAT can be corrected to make it valid. I have suffered this plight with firms suing BAC and C and they operate with the exact same protocol. They are in it to win it for themselves. Snakes crawl higher on the ground then these crooks.
I own far too much PSEC at this point but can't bring myself to let any go. That being said please imagine that PSEC has not been above board with their business practices. For example loaning infusing cash into the company and then getting it back in the form of dividends. If you can imagine this then you might also believe that PSEC could use the latest funnel cloud as an excuse to cut dividends when in reality they have not had enough real income to support the past payouts. Is this an example of driving the dividend to maintain share price?
Don't I recall last year when INTU was conservative with their estimates only a few weeks later to remark that TurboTax sales were well ahead of 2012. Take a look at the stock price reaction then and I do not believe INTU management has changed their colors regarding conservative estimates. Remember, the game is all about beating ESTIMATES
Early in 2013 KMP was on top of the world and another MLP, BPL was in the pits. From that time the reverse has occurred and I have asked on this board before why. Concerning the referenced article could the performance difference be due to the IRD model used by KMI. KMP pays a higher return and seems to be stronger than BPL but BPL has kicked butt and I do not know why. I own both but have a profit in BLP and a considerable loss in KMP.
Money can buy technology and Ebay has it. So don't count them out of any new acceptable technology. NIH is not a bad thing when you can buy someone else's hard work.
I have been here before with a different stock but similar story. After doubling, the company was bought out by Phizer for another double. This is not going to end well for the shorts and it is only a matter of time. Rhetoric doesn't change the facts and MNKD is destined IMO. Bought more today after a 30% gain already.
Sentiment: Strong Buy
In answering questions at the conference, Eliasek stated that a restatement would only increase income for shareholder and benefit them as a result. That being said, the burning question remains Why is PSEC fighting the SEC on this. I would like to start a dialogue on this as it appears that there is talk out of the side of his mouth.
That is what I am thinking. The entire structure is predicated on increasing fees at the expense of shareholders. It also results in insufficient NII to cover dividends and that leads to creative accounting. The burning question is whether what PSEC is doing is legal. I am toid that the SEC requirement is old and should have been followed. This could be the basis for ambulance chaser tipping the boat over. Unless criminal charges are filed by some agency, i.e. SEC, state attorney general, etc, I don't see the snakes getting much traction.
There was a pretty decent Seeking Alpha piece entitled "The worm has turned" that offers credible reasons why the drama may be coming to an end with KMI and KMP that hit today.
Your comment brings to mind a little more than a year ago Jim Cramer espousing the fact that KMP was one of his very favorite stocks after which the carnage began. Then last week in the lightening round he commented that he was 'worried that KMP had gotten too big' to continue its growth. Now I believe that was the Strong Buy signal
It seems to me that PSEC's statement that consolidation would provide more income to shareholders provides a legal argument for the ambulance chasers. That is, shareholders have been being short changed while KMI collected fees that evidently would have been funneled to shareholders if the combination had existed prior.
Big Pharmas are desperate for new products especially those that can be bought. Condiering Phizer's history with a similar product, I am guessing that they will partner with MNKD to produce Afreeza. Also, considering the premium MRK paid for IDIX, then you only have to extrapolate to know price is not the obstacle here. Pfizer would be better suited to act prior to July 15th as the price tag for partnering should be lower. Just my thoughts
With 17K shares I took 3500 off of the table after hours. Remember that short squeezes generally drive the price up initially higher than what will occur in the days immediately after JMHO
They are worse than could be explained even with expletives deleted. The lowest of the low
I read that it is not clear whether PSEC will have to consolidate current businesses in which it has majority ownership. Based on what management has said in prior statements would it not be a good thing for us if PSEC has to consolidate these as well? Less management fees and more income to distribute?